BIO-key International is trading 5.05% up at $2.49, with no confirmed company-specific announcement explaining the November 6 move. - The November 6 release only scheduled its third-quarter results and investor call for November 13. - The rise coincides with a broader technology rebound after the prior session’s sell-off, although software-sector weakness provides mixed context. - The November 3 Cipher integration is earlier news, not a confirmed catalyst for this increase.